U.S., Oct. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07859813) titled 'A Trial to Evaluate the Efficacy and Safety of ARO-INHBE in Adults With Metabolic Dysfunction-Associated Steatohepatitis' on July 10.
Brief Summary: This study is designed to evaluate the safety and efficacy of ARO-INHBE in adults with suspected metabolic dysfunction-associated steatohepatitis (MASH).
Study Start Date: Sept., 2026
Study Type: INTERVENTIONAL
Condition:
Metabolic Dysfunction-Associated Steatohepatitis
Intervention:
DRUG: ARO-INHBE
Subcutaneous (SC) injection
DRUG: Placebo
SC injection
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Arrowhead Pharmaceuticals
Published by HT Digital Content Services with perm...